| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.464 | 0 | 0 | 180.623 | 335.364 | 491.639 | 344.037 | 636.798 | 984.541 | 1.019.823 |
| Total Income - EUR | 1.464 | 0 | 0 | 180.623 | 335.378 | 510.708 | 416.308 | 622.281 | 984.831 | 1.020.190 |
| Total Expenses - EUR | 249 | 0 | 0 | 143.768 | 248.817 | 496.698 | 401.658 | 521.670 | 873.399 | 957.721 |
| Gross Profit/Loss - EUR | 1.215 | 0 | 0 | 36.855 | 86.561 | 14.009 | 14.651 | 100.611 | 111.432 | 62.468 |
| Net Profit/Loss - EUR | 1.171 | 0 | 0 | 35.049 | 83.207 | 9.093 | 10.448 | 94.388 | 103.110 | 51.354 |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 | 10 | 10 |
Check the financial reports for the company - Narcom Business Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 730 | 114.696 | 288.726 | 274.201 | 151.754 |
| Current Assets | 7.334 | 7.260 | 7.137 | 104.961 | 238.529 | 312.787 | 293.177 | 177.848 | 329.861 | 311.372 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 19.069 | 14.700 | 0 | 0 | 0 |
| Receivables | 2.488 | 2.463 | 2.421 | 95.064 | 223.156 | 283.175 | 271.720 | 174.592 | 275.660 | 291.001 |
| Cash | 4.846 | 4.797 | 4.716 | 9.898 | 15.373 | 10.543 | 6.756 | 3.256 | 54.202 | 20.371 |
| Shareholders Funds | 1.216 | 1.204 | 1.183 | 36.211 | 118.716 | 125.559 | 133.222 | 228.024 | 330.443 | 81.911 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.118 | 6.056 | 5.953 | 68.751 | 119.812 | 187.958 | 274.650 | 238.550 | 273.620 | 381.214 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2512 - 2512" | |||||||||
| CAEN Financial Year |
2512
|
|||||||||
Comments - Narcom Business Srl